Description
Tirzepatide (Mounjaro®) is a dual GIP and GLP-1 receptor agonist. Phase 3 SURMOUNT trials demonstrated industry-leading weight loss outcomes alongside significant metabolic improvements.
For research use only. Not for human consumption.
$39.90
Dual GLP-1 / GIP agonist · metabolic & weight research
Specification: 10 mg / vial
Availability: Usually ships within 2 days.
Structured product, pathway, quality-documentation, and laboratory-handling information.
BAC Water 3 mlSKU: BW3$4.90Add
BAC Water 10 mlSKU: BW10$13.90Add
Syringes 5× 1 ml U-100SKU: SYR5$2.49AddTirzepatide (Mounjaro®) is a dual GIP and GLP-1 receptor agonist. Phase 3 SURMOUNT trials demonstrated industry-leading weight loss outcomes alongside significant metabolic improvements.
For research use only. Not for human consumption.
Reviews
There are no reviews yet.